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Recent studies have postulated that distinct regulatory cascades control myogenic differentiation in the head
and the trunk. However, although the tissues and signaling molecules that induce skeletal myogenesis in the
trunk have been identified, the source of the signals that trigger skeletal muscle formation in the head remain
obscure. Here we show that although myogenesis in the trunk paraxial mesoderm is induced by Wnt signals
from the dorsal neural tube, myogenesis in the cranial paraxial mesoderm is blocked by these same signals. In
addition, BMP family members that are expressed in both the dorsal neural tube and surface ectoderm are also
potent inhibitors of myogenesis in the cranial paraxial mesoderm. We provide evidence suggesting that
skeletal myogenesis in the head is induced by the BMP inhibitors, Noggin and Gremlin, and the Wnt
inhibitor, Frzb. These molecules are secreted by both cranial neural crest cells and by other tissues
surrounding the cranial muscle anlagen. Our findings demonstrate that head muscle formation is locally
repressed by Wnt and BMP signals and induced by antagonists of these signaling pathways secreted by
adjacent tissues.
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Vertebrate locomotion crucially depends on trunk skel-
etal muscles, which all derive from the segmented par-
axial mesoderm termed somites (for review, see Christ
and Ordahl 1995). During the past decade, the tissues
and signaling molecules that induce the formation of
skeletal muscle from somites have been intensively
studied. These studies have indicated that somitic myo-
genesis in the trunk is affected by signals emanating
from the axial tissues, the surface ectoderm, and the lat-
eral plate mesoderm. Wnt family members expressed in
the dorsal neural tube work together with Sonic hedge-
hog (Shh) expressed in the notochord to activate myo-
genic bHLH gene expression (that is, Myf-5and MyoD)i n
the epaxial component of the myotome (Munsterberg et
al. 1995; Stern et al. 1995; Tajbakhsh et al. 1998; Borycki
et al. 2000; Gustafsson et al. 2002). In addition, Wnt sig-
nals from the dorsal ectoderm have been demonstrated
to up-regulate the expression of MyoD in the hypaxial
component of the myotome (Tajbakhsh et al. 1998). Fur-
thermore, BMP signals from the lateral plate have been
shown to delay the activation of myogenic bHLH gene
expression in the hypaxial muscle progenitors relative to
those that form the epaxial musculature (Pourquié et al.
1996). In contrast to our understanding of how skeletal
muscle is induced in the trunk, the tissues and signaling
pathways that induce the formation of skeletal muscle
in the head have not yet been elucidated.
In the vertebrate head, ∼40 skeletal muscles are pre-
sent, which, instead of serving for locomotion, rather
move the eye, control the cranial openings, or facilitate
food uptake and, in humans, speech (for review, see
Wachtler and Jacob 1986). Although the hypobranchial
muscles, the tongue muscles, and the muscles of the
posterior branchial arches (BAs), develop from the
somites, the remainder of the head muscles (that is, the
“genuine” head muscles) develop from the paraxial and
prechordal mesoderm located in the preotic levels of the
head. These latter head muscles encompass the extra-
ocular muscles and the muscles of the 1
st, 2
nd, and 3
rd
BAs. The BA muscle precursors stream from the cranial
paraxial mesoderm into the neighboring BAs to fill their
cores in concert with migratory cranial neural crest
(CNC) cells, which surround the muscle anlagen,
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face ectoderm. The CNC cells give rise to most of the
skeletal elements of the head and also serve as precursors
for connective tissues and tendons (Noden 1988; Couly
et al. 1993; Le Douarin et al. 1993).
It has long been suspected that the CNC cells may
play a role in patterning the head musculature (Noden
1983a,b; Couly et al. 1992; Kontges and Lumsden 1996;
Schilling and Kimmel 1997). Extirpation of CNC cells in
amphibians apparently does not block the formation of
cranial skeletal muscle but rather leads to defects in its
patterning (Sadaghiani and Thiebaud 1987; Olsson et al.
2001). However, these results must be interpreted with
caution, as neural crest cells are known to regenerate
following extirpation (Scherson et al. 1993; Saldivar et al.
1997; Vaglia and Hall 1999). Therefore, the cranial
muscles that formed in such operated embryos might
have been induced by regenerating neural crest tissue.
This view is supported by the phenotype of the zebrafish
mutant chinless that lacks both cranial cartilage and
skeletal muscle (Schilling et al. 1996). These authors
showed that the chinless gene is required in a cell-au-
tonomous fashion to promote the differentiation of cra-
nial neural crest-derived cartilage, but in a non-cell-au-
tonomous fashion to promote the formation of cranial
skeletal muscles, consistent with a positive role for the
CNC in head myogenesis (Schilling et al. 1996).
Although the genuine head muscles will finally ex-
hibit the same tissue architecture as muscles in trunk,
their development is remarkably distinct. The preotic
head mesoderm lacks any overt sign of segmentation and
never forms somites (for review, see Wachtler and Jacob
1986). In addition, components of the molecular clock
that drive trunk mesoderm segmentation and hence so-
mite formation are only transiently expressed in cranial
mesoderm (Jouve et al. 2002), which soon after gastrula-
tion merges to form a continuous strip of mesenchyme
on either side of the cranial neural tube (for review, see
Wachtler and Jacob 1986). Although the cranial meso-
derm gastrulates from the primitive streak before the
somitic mesoderm, myogenic differentiation is delayed
in the head relative to the trunk. In the chick, somitic
expression of the muscle regulatory gene Myf-5 appears
at stage 9–10, whereas in the BAs for instance, expres-
sion of this gene commences considerably later at stage
13–14, followed by the first sign of MyoD expression at
stage 15, and the onset of myosin heavy chain (MHC)
expression occurring not before stage 21 (Hacker and
Guthrie 1998; Noden et al. 1999).
When cranial paraxial mesoderm was grafted adjacent
to the axial tissues in the trunk, activation of the myo-
genic program in this ectopic position was inhibited, in-
dicating that signals from the axial tissues and surface
ectoderm that stimulate myogenesis in the somite are
unable to elicit this effect in cranial paraxial mesoderm
(Mootoosamy and Dietrich 2002). Consistent with the
notion that different signals activate myogenesis in the
head and trunk, distinct regulatory sequences have been
found to drive Myf-5 expression in these two regions of
the embryo (Hadchouel et al. 2000; Carvajal et al. 2001).
Furthermore, genetic studies have also indicated that
formation of head and trunk muscle is regulated by dis-
tinctly different regulatory pathways. Whereas skeletal
muscle formation in both regions of the embryo requires
either MyoD or Myf-5 (Rudnicki et al. 1993), mice lack-
ing both Myf-5 and Pax-3 are completely devoid of trunk
muscles yet retain normal head muscles (Tajbakhsh et
al. 1997). In addition, mice lacking both MyoR and Cap-
sulin display a deficit in jaw muscle formation, whereas
the trunk musculature remains normal (Lu et al. 2002).
In summary, embryological and genetic studies indicate
that distinct regulatory circuits control the formation of
head versus trunk skeletal muscles. In this work, we
explore the signals that modulate the head-specific pro-
gram of skeletal muscle formation.
Results
Cranial skeletal muscles develop adjacent to tissues
expressing Wnt, BMP, and Shh
In searching for possible regulators of head musculature,
we initially focused on signals that are known to affect
trunk myogenesis; namely, Wnts, Shh, and BMPs. To
evaluate if these signals might affect the formation of
head muscle, we first analyzed their expression in the
head region relative to that of MyoD and Myf-5 (Fig. 1).
MyoD (Fig. 1A,A,A) and Myf-5 (Fig. 1B,B,B) were de-
tected in the core of the 1
st BA as well as in some extra-
ocular muscles by whole-mount in situ hybridization at
stages 18–20. Similar analyses indicated that BMP-4 (Fig.
1C,C) and BMP-7 (Fig. 1D,D) are expressed in both the
dorsal neural tube and, in a regionalized fashion, in the
ectoderm lining the first two BAs. Both Wnt-1 and Wnt-
3a, which are known to signal via the canonical Wnt
pathway, are expressed in the dorsal neural tube lying
adjacent to the cranial paraxial mesoderm. In addition,
Wnt-13 (Wnt-2b) is strongly expressed both in the ecto-
derm of the 1
st and 2
nd BAs and in the dorsal neural tube
(Fig. 1E,E). Expression of Shh was detected in both the
endoderm underlying the BAs as well as in the posterior
ectoderm of the 2
nd BA (Fig. 1F,F). Thus, the cranial
muscle anlagen are surrounded by tissues secreting BMP,
Wnt, and Hedgehog family members, raising the possi-
bility that such signaling molecules might act to modu-
late the formation of skeletal muscle in the head.
An in vitro explant culture system to study
cranial myogenesis
To discern how BMP, Wnt, or Shh signals might affect
skeletal muscle formation in the head, we established an
in vitro explant culture system from the preotic head
mesoderm of the chick embryo (Fig. 2A). At stage 10, the
prechordal and the nonsomitic paraxial head mesoderm
form a merged strip of mesenchyme on either side of the
neural tube that will give rise to both the extraocular
muscles and the muscles of BAs 1–3. We therefore dis-
sected explants of this tissue in conjunction with both
Tzahor et al.
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paraxial mesoderm, endoderm, ectoderm; situated be-
tween the dotted lines displayed in Fig. 2B). In addition,
CPMEE explants contain migratory neural crest cells
(see below). These explants were embedded in collagen,
cultured in vitro for differing lengths of time, and har-
vested for RT-PCR analysis to evaluate gene expression.
To assay skeletal myogenesis, we followed the expres-
sion of both the myogenic regulators, MyoD and myo-
genin, and the differentiation marker, myosin heavy
chain (MHC). MyoD expression was first detected after 2
d of culture (Fig. 2C, lane 3), followed by the expression
of myogenin and MHC at day three (Fig. 2C, lane 4); all
three skeletal muscle markers continued to be robustly
expressed after4do fculture (Fig. 2D, lanes 1,3,5,7,9,
11,13). Although MyoD expression in the cranial meso-
derm in vitro was delayed relative to that observed in
vivo, its expression in cranial mesoderm explant cul-
tures preceded that of myogenin and MHC, similar to the
course of myogenic differentiation documented in this
tissue in vivo.
Inhibition of cranial myogenesis in vitro and in vivo
by BMP, Wnt, and Shh signals
We next tested the effect of exogenous BMP, Wnt, and
Shh on the progress of myogenic differentiation in stage
10 CPMEE cultures. Application of BMP-4 to these ex-
plants blocked skeletal myogenesis (Fig. 2D, lane 2; simi-
lar results were observed in 20/20 explants), reminiscent
of the repressive effects of BMP-4 on myogenesis in the
trunk. Surprisingly, infection of stage 10 explants with a
retrovirus encoding Wnt-3a also blocked myogenic dif-
ferentiation in these cultures (Fig. 2D, lane 4; similar
results were observed in 14/18 explants), suggesting that
Wnt signals, which promote trunk myogenesis, may act
to repress skeletal myogenesis in the head. Because sev-
eral Wnt family members, including Wnt-3a, are known
to signal via the “canonical” Wnt pathway by stabilizing
-catenin levels in the cell, we evaluated whether ex-
pression of a stabilized form of -catenin would also
block cranial myogenesis in explant culture. Indeed, ex-
pression of stabilized -catenin prevented skeletal myo-
genesis of CPMEE explants in vitro, similar to the effects
of Wnt-3a (Fig. 2D, lane 6; similar results were observed
in 6/9 explants). Likewise, forced expression of Wnt-13
(Wnt-2b), which also signals via the canonical Wnt path-
way, and is broadly expressed in BA ectoderm (Fig.
1E,E), blocked myogenesis in these explants (Fig.2D,
lane 8; similar results were observed in 6/8 explants).
Thus, as opposed to trunk paraxial mesoderm, where
Wnt signals have been found to promote skeletal myo-
genesis, the canonical Wnt signaling pathway blocks
skeletal muscle differentiation in cranial paraxial meso-
derm.
We also investigated if Shh signals, which in combi-
nation with Wnt-1/Wnt-3a induce myogenic differentia-
tion in the trunk, would affect skeletal muscle formation
in explants of the cranial mesoderm. We found that ad-
ministration of Shh blocked skeletal myogenesis in stage
10 CPMEE explants (Fig. 2D, lane 10; similar results
were observed in 10/14 explants). Likewise, the combi-
Figure 1. Expression of BMP-4, BMP-7, Wnt-13,a n d
Shh relative to MyoD and Myf-5 in the branchial arches.
(A–F). Whole-mount in situ hybridization of stage 17–20
chick embryos for the indicated genes shown in the
branchial arch (BA) region (lateral views, dorsal to the
left, anterior to the top). (A–F) Frontal sections at levels
designated by dashed lines in embryos depicted in A–F
for the indicated genes in the BA region. (I and II marks
the 1
st and 2
nd BAs, respectively).
Head skeletal muscle development
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ferentiation in these cultures (Fig. 2D, lane 14; similar
results were observed in 7/8 explants), whereas this same
combination of signals induced myogenesis in explants
of somitic mesoderm (Fig. 2D, lane 16; similar results
were observed in 4/4 explants). It should be noted that
not all signaling molecules expressed in the head
blocked myogenic differentiation of head mesoderm in
vitro, as FGF-19, which is expressed in a dynamic fash-
ion within the three germ layers during facial develop-
ment did not interfere with skeletal myogenesis in the
CPMEE cultures (Fig. 2D, lane 12; similar results were
observed in 5/5 explants). We conclude that Wnt and Shh
signals, which promote skeletal myogenesis in the
trunk, paradoxically block this differentiation program
in cranial paraxial mesoderm, and that BMP signals
block skeletal myogenesis in both head and trunk
muscle precursors.
To test if either BMP or Wnt signals would similarly
block skeletal myogenesis in head mesoderm in vivo, we
infected the right side of the cranial paraxial mesoderm
in stage 9 chick embryos in ovo with a retrovirus encod-
ing either BMP-4 or Wnt-3a (Fig. 2E–L). Eggs were sealed
and incubated for an additional 2 d. In situ hybridization
for MyoD (Fig. 2F,G) or Myf-5 (Fig. 2H–L) revealed a loss
of the BA musculature on the right side of embryos in-
fected with these retroviruses (Fig. 2G,I), and normal ex-
pression of these same markers in the BAs on the control
left side of the embryos (Fig. 2F,H). To detect viral
spreading, we performed in situ hybridization for the vi-
ral transcripts (shown in light blue; Fig. 2J,K,L). This pro-
cedure revealed that Wnt-3a-infected BA tissue failed to
express Myf-5, whereas infected somitic tissue (which
was infected by virus that was spread bilaterally under-
neath the dorsal ectoderm) robustly expressed Myf-5 (Fig.
2L). In addition, implantation of beads laden with Shh
into the cranial region blocked the formation of nearby
skeletal muscles in vivo (S. Dietrich, unpubl.). Thus,
Wnt, BMP, and Shh signals are potent inhibitors of cra-
nial skeletal muscle formation both in vitro and in vivo.
Figure 2. Ectopic BMP, Wnt, and Hedgehog signals can
block myogenesis in the cranial paraxial mesoderm. (A)
Diagram of a stage 10 chick embryo, showing the loca-
tion of the cranial paraxial mesoderm (red) adjacent to
the neural tube (blue) and anterior to the first pair of
somites (purple). (B) Scheme of the germ layers included
in the dissected tissue, showing the cranial paraxial me-
soderm covered dorsally by the ectoderm and ventrally
by the endoderm, termed CPMEE. (C) Skeletal myogen-
esis in CPMEE explants cultured in vitro. CPMEE ex-
plants were dissected and cultured in vitro for the indi-
cated number of days prior to harvest. RT-PCR analysis
was performed to monitor expression of the indicated
genes. (D) The effect of various signaling molecules on
myogenesis in cranial and trunk paraxial mesoderm. Ex-
plants of either CPMEE (lanes 1–14) or somites I–III
(lanes 15,16) isolated from stage 10 chick embryos were
cultured in vitro. Explants were cultured in medium
containing either BMP-4 (lane 2), Shh (lanes 10,14,
15,16), or FGF-19 (lane 12), or infected with a nondefec-
tive retrovirus (RCAS) encoding either GFP (lanes
3,5,7,13,15), Wnt-3a (lanes 4,14,16), a stabilized form of
-catenin (lane 6), or Wnt-13 (lane 8). A representative
experiment is shown; however, similar results were ob-
tained in at least four independent experiments. (E) Cra-
nial paraxial mesoderm of stage 9 embryos targeted for
infection by RCAS viruses (blue) in F–L.( F,G) Effect of
RCAS-BMP-4 infection of the cranial paraxial meso-
derm. MyoD expression in either the control side (left)o r
the RCAS-BMP-4-infected side (right), respectively. The
asterisk marks developing tongue muscles that migrate
from occipital somites, closed arrowheads identify BMP-
4-infected branchial arches. (H,I) Effect of RCAS-Wnt-3a
infection of the cranial paraxial mesoderm. Myf-5 ex-
pression in either the control side (left)o rt h eRCAS-
Wnt-3a-infected side (right), respectively. The asterisk marks developing tongue muscles that migrate from occipital somites. The
closed arrowhead identifies Wnt-3a-infected branchial arch. (J,K) Secondary in situ hybridization to detect ectopic viral gene expression
(light blue; open arrowhead). Light blue staining in the branchial arch region of J is from staining on the contra-lateral RCAS-Wnt-
3a-infected right side of the embryo; see L.( L) A frontal section of the embryo depicted in J and K (at the level labeled with a dashed
line) documents viral expression (light blue) in both the right side of the branchial arches (which lack Myf-5 expression; open
arrowhead) as well as the somitic mesoderm (which retains Myf-5 expression; closed arrowhead).
Tzahor et al.
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myogenesis in vitro
Our findings indicate that the formation of genuine head
muscles is blocked by BMP, Wnt, and Shh signals. Given
that a prominent site of expression for these signaling
molecules is the neural tube and that cranial muscle, and
in particular the BA musculature, develops at sites dis-
tant from the neural tube, we reasoned that BMP, Wnt,
and/or Shh secreted by the neural tube might act to pre-
vent premature myogenic differentiation of the meso-
derm prior to its migration away from the axial tissues.
To investigate if the axial tissues secrete inhibitors of
cranial skeletal muscle differentiation, we cultured stage
10 CPMEE explants in either the absence or presence of
the adjacent neural tube (from the hindbrain region) and
underlying notochord. When cultured in the absence of
the neural tube/notochord, stage 10 CPMEE explants un-
derwent robust myogenic differentiation (Fig. 3A, lane 1;
similar results were observed in 22/24 explants). In con-
trast, when cultured in the presence of the axial tissues,
the explants failed to show significant levels of muscle
differentiation. (Fig. 3A, lane 2; similar results were ob-
served in 14/15explants). Thus, signals from the neural
tube/notochord block cranial myogenesis in vitro, indi-
cating that muscle differentiation in the head, in con-
trast to the trunk, may be actively inhibited in the vi-
cinity of the axial tissues. Next, we investigated if the
inhibitory signal(s) that blocks skeletal myogenesis in
cranial paraxial mesoderm explants resides in either the
dorsal or ventral region of the axial tissues. Activation of
the skeletal muscle differentiation program was effi-
ciently blocked in stage 10 explants cultured in the pres-
ence of only the dorsal half of the neural tube (Fig. 3A,
lane 4; similar results were observed in 8/8 explants). In
contrast, myogenesis took place in similar explants cul-
tured with only the ventral half of the neural tube and
notochord (Fig. 3A, lane 6; similar results were observed
in 5/5 explants). In other words, dorsal neural tube abla-
tion restores cranial myogenesis in CPMEE explants.
Thus, skeletal myogenesis in the cranial paraxial meso-
derm is strongly inhibited by a signal(s) emanating from
the dorsal neural tube, and is consistent with the expres-
sion of Wnt-1, Wnt-3a , and BMP family members in this
region of the neural tube. Because skeletal muscle differ-
entiation in CPMEE explants took place in the presence
of the ventral midline tissues (that is, the notochord and
floor plate) in vitro, it suggests that physiological levels
of Shh expressed by these tissues do not block myogen-
esis in the cranial paraxial mesoderm.
To investigate if Wnt signals from the neural tube
block skeletal myogenesis in explants containing cranial
mesoderm, we investigated whether administration of
the Wnt antagonist Frzb-IgG (Tzahor and Lassar 2001) to
explants of cranial paraxial mesoderm cultured in the
presence of the dorsal neural tube would restore skeletal
myogenesis in such cultures. Indeed, although coculture
of stage 10 CPMEE with the dorsal neural tube com-
pletely blocked the expression of MyoD (Fig. 3B, lane 1),
addition of Frzb-IgG negated the inhibitory effects of the
dorsal neural tube and induced the expression of MyoD
in 40% of such treated cultures (Fig. 3B, lane 2; similar
results were observed in 4/10 explants). These findings
indicate that Wnt signals from the dorsal neural tube
repress skeletal muscle formation in cocultured cranial
paraxial mesoderm, and suggest that such signals may
serve to block premature cranial myogenesis in the vi-
cinity of the neural tube.
Expression profile of BMP and Wnt antagonists
in the head
In the chick embryo, BMP and Wnt signals are secreted
by both the dorsal neural tube from neurulation stages
onward and are also present in the surrounding tissues
when muscle precursors enter the BAs. We therefore
speculated that a mechanism must be in place to antago-
nize both BMP and Wnt signals in the BAs to promote
Figure 3. Inhibition of myogenesis in the cranial paraxial me-
soderm by signals from the dorsal neural tube. (A) Diagrams of
transverse sections through explants show the cranial paraxial
mesoderm (red) in relation to the adjacent axial tissues (blue).
RT-PCR analysis of gene expression in explants that had been
isolated from stage 10 chick embryos and cultured for4di n
either the absence (lane 1) or the presence of the adjacent neural
tube and notochord (NT/nc; lanes 2,3,5), the dorsal neural tube
(dNT; lane 4) or the ventral neural tube and notochord (vNT/nc;
lane 6). Skeletal myogenesis was observed in 1/15explants co-
cultured with NT/nc (lanes 2,3,5), in 0/8 explants cocultured
with dNT (lane 4), and in 5/5 explants cocultured with vNT/nc
(lane 6). (B) Administration of Frzb-IgG can induce MyoD ex-
pression in CPMEE explants cultured in the presence of the
dNT. CPMEE plus the adjacent dorsal neural tube were isolated
from stage 10 chick embryos and were cultured in either the
absence (lane 1) or presence (lane 2) of Frzb-IgG. MyoD induc-
tion was observed in 40% of such explants (n = 10).
Head skeletal muscle development
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to explore this possibility by investigating the expression
patterns of BMP and Wnt antagonists at the sites of the
developing cranial muscle anlagen. We found that Nog-
gin is expressed in migrating CNC cells at stage 11 just
prior to the onset of myogenic differentiation (Fig. 4A).
This expression was retained by tissues surrounding the
eye but lost by the CNC cells that had migrated into the
BAs at stage 16 (Fig. 4B). At this stage, however, expres-
sion of a different BMP inhibitor, Gremlin, commenced
in the BAs region (Fig. 4C,D) in the subectodermal layer
of the CNC-derived BA mesenchyme and in the pharyn-
geal endoderm in stage 21 embryos (Fig. 4E,F).
At stage 11, expression of the Wnt antagonist Frzb
overlapped with that of Noggin in the migrating CNC
cells (Fig. 4G). Later, Frzb is expressed by the CNC-de-
rived mesenchyme of the BAs, and displays a wider dis-
tribution than the BMP antagonists in this tissue (Fig.
4H–J). Similar to Gremlin, however, the expression of
Frzb was not limited to CNC-derived tissues, but in-
cluded the ectoderm covering the distal arches (Fig. 4I).
To more closely investigate the spatial relationship of
the cranial muscle anlagen and Frzb expressing mesen-
chyme, we performed in situ hybridization of adjacent
sections at stage 19. This analysis revealed a striking
complementary expression pattern for Frzb and Myf-5.
The crest-derived mesenchyme of such embryos ex-
pressed Frzb (Fig. 4J), surrounding a mesodermal core
expressing Myf-5 (Fig. 4K). Thus, at the time of myogenic
differentiation, tissues surrounding the myogenic meso-
derm, in particular CNC cells, provide the means to an-
tagonize both BMP and Wnt signals and thereby may act
to promote myogenic differentiation. We therefore ana-
lyzed the role that CNC cells and BMP or Wnt inhibitors
might play during cranial muscle formation in vitro and
in vivo.
CNC cells can induce cranial myogenesis in vitro
CNC cells start to leave the neural folds prior to neural
tube closure at stage 8+, and by stage 10, most of the
CNC cells have left the neural folds and reside between
the cranial mesoderm and ectoderm. We therefore rea-
soned that the myogenic differentiation observed within
stage 10 CPMEE explants may be stimulated by signals
secreted by CNC cells present within these explants.
Consequently, we investigated whether explants taken
from stage 8 embryos prior to CNC migration would
undergo myogenic differentiation. Explants dissected at
stage 10 and cultured for3di nvitro robustly expressed
MyoD, myogenin, and MHC (Fig. 5A, lane 6; similar re-
sults were obtained in 38/44 explants). In striking con-
trast, explants dissected at stage 8 failed to differentiate
into skeletal muscle after3di nculture (Fig. 5A, lane 3;
similar results were observed in 22/26 explants). Al-
though both stage 8 and stage 10 CPMEE explants ex-
pressed Wnt-13 and BMP-4 (Fig. 5A) in the ectodermal
layer (see following), only stage 10 explants were popu-
lated by CNC cells, as evidenced by the expression of
several neural crest markers including Pax-3, Slug, Id2,
and Noelin (Fig. 5B, lane 2). Notably, Frzb, Noggin, and
Gremlin, which are expressed by CNC cells, were de-
tectable in stage 10 but not stage 8 CPMEE explants (Fig.
5B, lane 2). Thus, activation of skeletal myogenesis in
explants of cranial paraxial mesoderm indeed correlated
with the presence of Frzb/Noggin/Gremlin expressing
CNC cells within these explants.
Figure 4. The BMP antagonists Gremlin and
Noggin and the Wnt antagonist Frzb are ex-
pressed by both the cranial neural crest and
other facial tissues. Gene expression analysis of
the BMP antagonists Noggin and Gremlin (A–F)
and the Wnt antagonist Frzb (G–J). (A,B) Noggin
expression. (A) Whole-mount in situ hybridiza-
tion of Noggin, showing its expression in mi-
grating CNC cells at stage 11 (dorsal view, an-
terior to the top). (B) At stage 16, Noggin expres-
sion is reduced in the BA region (lateral view,
d o r s a lt ot h eright, anterior to the top). (C–F)
Gremlin expression. (C) Lateral view and (D)
frontal section (anterior to the top) at stage 16.
Gremlin is expressed in a subset of CNC cells
beneath the surface ectoderm that migrate to
the 2
nd BA at stage 16. (E) Lateral view and (F)
frontal section (pharynx to the left, surface of the embryo to the right) at stage 21. Note enhanced expression of Gremlin in the
subectodermal mesenchyme and in addition, the pharyngeal endoderm (F, arrowhead). (G–K) Frzb expression. Frzb is expressed in
migrating cranial neural crest cells at stage 11 (G, dorsal view) and in the cranial neural crest-derived mesenchyme of the BAsa ts t a g e
18 (H, lateral view). (I) Frontal section of the embryo in H (orientation as in F). In addition to its expression in the BA mesenchyme,
Frzb is also expressed in the surface ectoderm (arrowhead). (J,K) Adjacent frontal sections through the BAs of a stage 19 chick embryo
stained for Frzb (J) and Myf-5 (K), pharynx toward the top left corner. Note the complementary expression patterns of Frzb in neural
crest-derived mesenchyme and Myf-5 in paraxial mesoderm-derived cells located in the core of the BA.
Tzahor et al.
3092 GENES & DEVELOPMENT
  Cold Spring Harbor Laboratory Press  on September 29, 2010 - Published by  genesdev.cshlp.org Downloaded from To directly test if CNC cells express an activator of the
cranial skeletal muscle differentiation program, we co-
cultured stage 8 explants with either purified CNC cells
or medium conditioned by CNC cells (Fig. 5C). As dis-
cussed earlier, skeletal myogenesis occurred in only
about 12% of CPMEE explants dissected from stage 8
chick embryos that were cultured alone (Fig. 5C, lanes
1,3; similar results were observed in 7/8 explants). In
contrast, when cocultured with either CNC cells (Fig.
5C, lane 2; similar results were observed in 6/8 explants)
or with medium conditioned by CNC cells (Fig. 5C, lane
4; similar results were observed in 4/6 explants), robust
skeletal myogenesis was observed in stage 8 explants.
Control cultures containing only CNC cells expressed
the various neural crest markers, yet failed to express
any skeletal muscle differentiation markers (Fig. 5C,
lane 5; similar results were observed in 5/5 explants).
Thus, CNC cells secrete a factor(s) that can promote
skeletal myogenesis of cranial paraxial mesodermal cells
in vitro.
BMP and Wnt antagonists expressed by the CNC cells
mimic the muscle-inducing activity of this tissue
in vitro
We found that the BMP antagonists Noggin and Gremlin
and the Wnt antagonist Frzb are all expressed by cranial
neural crest cells in vivo and in vitro. We therefore
speculated that these secreted factors may act to stimu-
late cranial myogenesis by blocking the repressive ef-
fects of BMP and Wnt signals on this process. To evalu-
ate if BMP antagonists might promote skeletal myogen-
esis in explant culture, we first cultured stage 8 explants
with either Gremlin or Noggin (Fig. 5D). Infection of
stage 8 explants with an avian retrovirus programmed to
express Gremlin (Fig. 5D, lane 2; similar results were
Figure 5. Activation of myogenesis in ex-
plants of cranial paraxial mesoderm by cra-
nial neural crest cells, and by antagonists of
BMP and Wnt signaling. (A) Myogenesis oc-
curs in stage 10 but not stage 8 CPMEE
explants. CPMEE explants dissected from
stage 8 or 10 embryos were cultured for the
indicated period of time. Transcript levels
of the indicated genes were monitored
by RT-PCR analysis. (B) Myogenesis in
CPMEE explants correlates with the pres-
ence of the cranial neural crest. RT-PCR
analysis of gene expression in CPMEE ex-
plants that were isolated from either stage
8 (lane 1) or stage 10 (lane 2) chick embryos
and cultured in vitro for 4 d. (C) CNC cells
or CNC-conditioned medium can induce
myogenesis in stage 8 CPMEE explants.
S t a g e8e x p l a n t sw e r ec u l t u r e df o r4de i t h e r
in the absence (lanes 1,3) or in the presence
of either CNC cells (CNC cells; lane 2), or
medium conditioned by CNC cells (CNC
cm, lane 4). In addition, CNC cells were
cultured alone (lane 5). Skeletal myogen-
esis was observed in 12% of explants dis-
sected from stage 8 chick embryos that
were cultured alone (lanes 1,3; n = 8); in
75% of stage 8 explants that were cultured
in the presence of isolated CNC cells (lane
2; n = 8); and in 67% of stage 8 explants
that were cultured in the presence of con-
ditioned medium harvested from neural
crest cells (lane 4; n = 6). Isolated CNC
cells cultured alone expressed all neural crest markers but failed to express skeletal muscle differentiation markers (lane 5). In B and
C, the skeletal muscle differentiation markers are identified by a red bar on the right; the neural crest markers are identified by a grey
bar. (D) Administration of BMP antagonists can elicit myogenesis in stage 8 CPMEE explants. Stage 8 CPMEE explants were infected
with a retrovirus encoding either GFP (lane 1)o rGremlin (R-Gremlin, lane 2; myogenesis was observed in 8/10 such explants) and
cultured for 4 d. Similar explants were treated with medium conditioned by either control cells (lane 3) or Noggin-expressing cells
(Noggin, lane 4; myogenesis was observed in 14/20 such explants). (E) Noggin and Frzb synergistically activate MyoD expression in
stage 8 CPMEE explants. Stage 8 CPMEE explants were treated with either soluble Frzb-IgG (lane 2), medium conditioned by
Noggin-expressing cells (lane 3), or both Frzb-IgG and Noggin-containing medium (lane 4). The transcript levels of Nkx2.5 and
ventricular Myosin Heavy Chain (vMHC) were evaluated to assay for cardiogenesis. (F) Ectodermal signals suppress myogenesis in
stage 8 CPMEE explants. Stage 8 or stage 10 cranial paraxial mesendoderm exp l a n t sw e r ec u l t u r e df o r4di ne i t h e rt h ep r e s ence or
absence of ectoderm as indicated. Similar results were obtained in multiple independent experiments.
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in Noggin-conditioned medium (Fig. 5D, lane 4; similar
results were observed in 14/20 explants) led to activation
of the skeletal muscle differentiation program, suggest-
ing that these molecules can indeed trigger myogenic
differentiation of the cranial mesoderm. In contrast, ad-
ministration of the Wnt antagonist Frzb-IgG to these
same explants failed to induce skeletal muscle differen-
tiation markers, but rather induced cardiogenesis as
monitored by the expression of Nkx2.5and ventricular
MHC (Fig. 5E, lane 2; similar results were observed in
6/9 explants) as previously reported (Tzahor and Lassar
2001). However, administration of Noggin and Frzb-IgG
in combination (Fig. 5E, lane 4; similar results were ob-
served in 5/6 explants) augmented the expression of
MyoD relative to that induced by Noggin alone (Fig. 5E,
lane 3), and repressed the extent of cardiogenesis relative
to that induced by FrzB-IgG alone (Fig. 5E, lane 2). These
results suggest that the combinatorial action of BMP and
Wnt antagonists secreted by the cranial neural crest may
work to promote the differentiation of cranial mesoder-
mal cells into skeletal rather than cardiac myoblasts.
Because BMP signals repress skeletal myogenesis in
stage 8 CPMEE explants, and BMPs are prominently ex-
pressed in the facial ectoderm, we examined whether
removal of the ectoderm from stage 8 cranial paraxial
mesendoderm (CPME) explants would allow skeletal
muscle differentiation to occur in this tissue, which
lacks a cranial neural crest component. Indeed, culturing
stage 8 CPME explants in the absence of ectoderm led to
a robust induction of skeletal muscle differentiation,
which correlated with the absence of both Wnt-13 and
BMP-4 in the explants (Fig. 5F, cf. lanes 1 and 2). In
contrast, skeletal muscle differentiation in stage 10
CPMEE versus CPME explants was unaffected by the
removal of the ectoderm (Fig. 5F, lanes 3,4). Thus, in
addition to signals from the dorsal neural tube, inhibi-
tory signals from the ectoderm block muscle differentia-
tion in stage 8 cranial paraxial mesoderm.
Ectopic expression of a Wnt antagonist promotes
cranial myogenesis in vivo
Because Frzb-expressing cells surround a core of MyoD/
Myf-5-positive cells in the BAs (Fig. 4J,K), and this in-
hibitor counteracts Wnt signals from the dorsal neu-
ral tube that repress skeletal muscle differentiation of
CPMEE explants in vitro (Fig. 3B), we speculated that
inhibition of Wnt signaling by Frzb may promote skel-
etal muscle differentiation in the BAs in vivo. To explore
this possibility, we applied Frzb-IgG to the cranial par-
axial mesoderm in vivo, reasoning that increased levels
of Frzb might, in conjunction with endogenous BMP in-
hibitors expressed in the embryo, act to accelerate the
expression of skeletal muscle differentiation markers in
vivo. Indeed, implantation of pellets of 293 cells, engi-
neered to express the Frzb-IgG fusion protein, into stage
9 cranial paraxial mesoderm induced premature expres-
sion of MyoD in the vicinity of the Frzb-IgG cell pellet in
the BA region (Fig. 6B,D). Notably, the induction of
MyoD by Frzb-IgG cells was restricted to only a few cell
layers adjacent to the cell pellet, consistent with the lo-
calized expression of FrzB-IgG to tissue immediately ad-
jacent to the Frzb-IgG expressing cells (Fig. 6D). In the
BAs of either stage-matched unoperated embryos or of
embryos implanted with IgG control cells, MyoD expres-
sion was not detected (Fig. 6A,C; data not shown). These
findings are consistent with our in vitro results, indicat-
ing that Wnt signals secreted by the neural tube repress
cranial myogenesis, and suggest that myogenic differen-
tiation in the head is stimulated by Wnt antagonists.
Figure 6. Ectopic application of the Wnt antagonist Frzb in-
duces MyoD expression in vivo. (A) Lateral view of the BA re-
gion of a control embryo and (B) an embryo in which a pellet of
293 cells, programmed to express Frzb-IgG, was inserted into
the cranial paraxial mesoderm on the right side at stage 9. After
2 d of reincubation, the embryo was harvested and MyoD ex-
pression was analyzed by whole-mount in situ hybridization.
Following in situ hybridization, the embryos were immuno-
stained with an antibody against IgG to identify the location of
the Frzb-IgG-expressing cells (indicated by dotted line). The BA
containing the Frzb-IgG cells shows robust levels of MyoD ex-
pression (B). (C,D) Frontal sections through the BAs of the em-
bryos displayed in A and B. Arrowhead in D points to location
of ectopic MyoD expression in the BA mesenchyme located
adjacent to Frzb-IgG cells (indicated by dotted line). For con-
trols, we used staged-matched embryos that were mock-oper-
ated in the same manner and incubated for the same time period
(A,C). Other controls included implantation of pellets of either
293 cells, 293-IgG cells, COS7 cells, or CHO cells into the cra-
nial paraxial mesoderm on the right side of a stage 9 chick
embryo, which in all cases failed to induce MyoD expression in
the BAs (data not shown).
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activate cranial myogenesis in vivo
As discussed above, we have found that BMP and Wnt
signals can block cranial myogenesis, whereas BMP and
Wnt antagonists promote this process. A prominent site
of expression for these BMP and Wnt inhibitors in the
head are the CNC cells, which in vitro also promote
skeletal myogenesis. To investigate whether CNC cells
are required for skeletal myogenesis in vivo, we bilater-
ally ablated the dorsal half of the neural plate from the
diencephalic levels to the level of rhombomere 5/6 at
stage 8, prior to the onset of CNC cell emigration (Fig.
7A). The embryos were reincubated until stage 18–19
and analyzed for the presence of Myf-5 (Fig. 7C,E, blue
staining, showing control and operated embryos, respec-
tively, n =7 )o rMyoD (data not shown, n = 2) by whole-
mount in situ hybridization. We monitored whether re-
sidual CNC cells were present in the BA region by ana-
lyzing the expression of the neural crest cell markers
Dlx5 (data not shown, n =3 ) o r Frzb (Fig. 7B,D, blue
staining, showing control and operated embryos, respec-
tively; Fig. 7E, showing an operated embryo; red staining,
n = 4). The neural crest-ablated embryos, although ex-
hibiting malformed, size-reduced, and often develop-
mentally retarded heads, all developed BAs. In striking
contrast to stage-matched control embryos (Fig. 7B,C),
the BAs in CNC-ablated embryos lacked neural crest-
associated expression of Dlx5 (data not shown) and dis-
played a significant decrease in Frzb expression (Fig. 7,
cf. B, D and E), suggesting that a significant fraction of
neural crest-derived mesenchyme was absent from these
structures. Interestingly, however, faint expression of
Frzb throughout the BAs and stronger expression in both
the ectoderm overlying the trigeminal ganglion and the
distal ectoderm of the BAs persisted in such manipulated
embryos (Fig. 7D,E, arrows), suggesting that Frzb may be
expressed by either residual CNC and/or nonneural
crest-derived tissues in such operated embryos. Accord-
ingly, Myf-5 (Fig. 7E; blue staining) or MyoD (data not
shown) expression was still detectable in both the BA
muscle anlagen and in the anlagen of the extraocular
muscles. These results indicate that induction of myo-
genesis in the BAs can occur following extirpation of
Figure 7. Myogenic bHLH genes are expressed in the
branchial arches after ablation of the cranial neural
crest; a model for cranial skeletal muscle induction. (A)
Scheme of in ovo neural crest cell ablation. At stage 8,
the dorsal half of the neural plate from diencephalic
levels to rhombomere 5/6, anterior to the first somite
(som1), was excised bilaterally as indicated. (B–E) Lat-
eral views of the BA region of either control (B,C)o r
operated (D,E) embryos at stage 18–19 (dorsal is to the
left, anterior to the top). (B) Control embryo stained for
Frzb. Note the widespread expression of Frzb, including
the trigeminal (nV) and facial (nVII) ganglia, the neural
crest cells in the BA mesenchyme, and the ectoderm
covering the trigeminal and the distal region of the BAs
(arrows). (C) Expression of Myf-5 in a control embryo.
The anlagen of the muscles in BA I–III and of the lateral
rectus muscle (lr) are indicated. (D) Neural crest ablated
embryo stained for Frzb. Although neural crest cell-
associated expression of Frzb is significantly dimin-
ished in the head region, Frzb is still present in the
ectoderm overlying the trigeminal ganglia and the dis-
tal ectoderm of the BAs (arrows). (E) Neural crest ab-
lated embryo stained for Myf-5 in blue and Frzb in red.
Note that Myf-5 expression is still detectable both in
the lateral rectus and in the BAs. In this embryo, low
levels of Frzb are detectable throughout the BAs and
higher levels are found in the ectoderm overlying the
trigeminal ganglia and the distal ectoderm of the BAs
(arrows). (dienc) diencephalon; (r5/6) rhombomeres 5
and 6. (F–H) Head muscle formation is cued by a com-
bination of negative and positive signals from surrounding tissues. (F) Cranial neural crest cells (CNC, shown as grey) migrate away
from the dorsal neural tube and into the region of the cranial paraxial mesoderm (red). While lying adjacent to the neural tube, muscle
formation in the cranial paraxial mesoderm is blocked by BMP and Wnt signals from the dorsal neural tube (G) In the trunk, Wnt
signals from the dorsal neural tube in combination with Shh signals from the notochord and floor plate promote epaxial myogenesis
in the somites. (H) At sites of head muscle formation such as the BAs, CNC cells, which have migrated from the dorsal neural tube,
surround a core of muscle precursors derived from the cranial paraxial mesoderm. BMP-4, BMP-7, and Wnt-13 signals from the BA
ectoderm repress skeletal muscle differentiation in the mesodermal core. The BMP antagonists Noggin and Gremlin work together
with the Wnt antagonist Frzb, which is expressed by both CNC cells and other BA tissues, to override BMP and Wnt inhibition and
thereby promote skeletal myogenesis.
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at a low but detectable level in the BA region following
ablation of the CNC, it is possible that expression of this
molecule by either residual CNC cells or by other tissues
in the head may compensate for the absence of the ma-
jority of the CNC to induce head muscle formation.
Discussion
Myogenesis in cranial and trunk paraxial mesoderm is
controlled by distinct regulatory circuits
In this work, we demonstrate that the signals that in-
duce myogenesis in the cranial versus the trunk paraxial
mesoderm are notably distinct. Although signals from
the dorsal neural tube promote myogenesis in the trunk,
such signals block myogenesis of the cranial paraxial
mesoderm in vitro. Indeed, expression of Wnt family
members expressed in either the dorsal neural tube
(Wnt-3a) or surface ectoderm (Wnt-13), or forced expres-
sion of stabilized -catenin, which stimulates the ca-
nonical Wnt-signaling pathway, all blocked myogenesis
in cranial paraxial mesoderm explants, and in the case of
Wnt-3a, blocked myogenesis in the BA region in vivo. In
striking contrast, Wnt family members expressed in ei-
ther the dorsal neural tube or in surface ectoderm over-
lying the somites have been documented to promote
skeletal myogenesis in this tissue (Takada et al. 1994;
Munsterberg et al. 1995; Stern et al. 1995; Capdevila et
al. 1998; Ikeya and Takada 1998; Tajbakhsh et al. 1998).
Wnt-1 and Wnt-3a, which cooperate with Shh to stimu-
late myogenesis in the trunk and suppress myogenic dif-
ferentiation of cranial mesoderm, are known to signal
via the canonical Wnt signaling pathway by stabilizing
intracellular -catenin levels. Because overexpression of
a stabilized form of -catenin can mimic the effects of
Wnts-1, -3a, and -13 on cranial muscle formation, it
seems most likely that the effects of these Wnts are me-
diated by the canonical Wnt signaling pathway. Whereas
in the trunk activation of this pathway triggers myo-
genic differentiation, in the head myogenic differentia-
tion is blocked. It will be interesting to determine if the
opposite effects of increased -catenin levels on myogen-
esis in the head and trunk are both mediated by induc-
tion of TCF/LEF1 transcriptional activity. In contrast to
the differential effects of Wnt signaling on cranial versus
trunk paraxial mesoderm, BMP signals were found to
repress myogenesis in either cranial (this report) or trunk
(Pourquié et al. 1996; Hirsinger et al. 1997; McMahon et
al. 1998; Reshef et al. 1998; Amthor et al. 1999) paraxial
mesoderm. Consistent with the inhibitory affects of
BMPs and Wnt signals on cranial muscle formation, we
have found that induction of skeletal muscle in stage 8
cranial paraxial mesodermal explants requires the pres-
ence of BMP inhibitors such as Noggin and Gremlin, and
is augmented by Wnt inhibitors such as Frzb. Interest-
ingly, both BMP and Wnt signaling antagonists are se-
creted by both CNC cells and other tissues surrounding
the cranial muscle anlagen.
Both Wnt and BMP signals may act to restrict head
muscle formation in the vicinity of the neural tube
To test whether the levels of BMP and Wnt signaling
present in the embryo have the same effect on myogenic
differentiation as purified factors, we cultured the cra-
nial paraxial mesoderm with either the neural tube/no-
tochord complex, the dorsal neural tube, or the ventral
neural tube plus notochord. We found that both the neu-
ral tube/notochord complex or the dorsal neural tube
alone blocked myogenic differentiation of cranial par-
axial mesoderm similar to overexpression of either BMP
or Wnt molecules in this tissue. The repressive effect of
the dorsal neural tube on cranial myogenesis could be
partially reversed (in 40% of explants) by administration
of the Wnt antagonist Frzb-IgG. These findings suggest
that Wnt signals from the dorsal neural tube may act to
inhibit or delay cranial myogenic differentiation in the
embryo. However, although application of ectopic Shh
was also able to block myogenesis of cranial mesoderm
both in vitro and in vivo, coculture of this tissue with
the ventral neural tube/notochord complex, which ex-
presses presumably lower physiological levels of Shh, did
not apparently interfere with this process. In this latter
experiment, our assay did not distinguish whether myo-
genesis was selectively inhibited in cranial paraxial me-
sodermal cells that lay close to the ventral midline struc-
tures as opposed to mesodermal cells that had migrated
away from the floor plate and notochord. However, be-
cause extirpation of both the notochord and floor plate of
the neural tube in the cranial region of stage 10 chick
embryos failed to affect head muscle formation in vivo
(S. Dietrich, unpubl.), it seems most likely that physi-
ological levels of Shh present in the notochord and floor
plate of the neural tube may not be involved in the con-
trol of cranial muscle formation.
In the trunk, the dorsal neural tube specifically stimu-
lates the development of the epaxial muscle anlagen,
which remain in the vicinity of the axial midline tissues
to give rise to the deep muscles of the back (Burke and
Nowicki 2003). In contrast, cranial skeletal muscle an-
lagen develop at a distance from the dorsal neural tube
(Noden 1983a, 1986; Couly et al. 1992; for review, see
Wachtler and Jacob 1986), in either the core of the BAs
(branchiomeric muscles) or around the eye (extraocular
muscles). It is therefore conceivable that both Wnt and
BMP signals secreted by the dorsal neural tube block
cranial muscle differentiation in the vicinity of the axial
tissues. In addition, both BMP family members and Wnt-
13 (Wnt2b), which are able to block muscle differentia-
tion in cranial mesoderm explants, are secreted by the
ectoderm overlying the BAs, suggesting that even at
their final location, differentiation of cranial muscle pre-
cursors may be repressed by ectodermal signals. Indeed,
in stage 8 CPMEE explants, we found that removal of
BMP-4/BMP-7/Wnt-13-expressing ectoderm derepressed
skeletal muscle differentiation in this tissue. In the limb,
BMP molecules limit the rate of myogenic differentia-
tion to prevent the exhaustion of the myogenic precursor
pool (Amthor et al. 1999). Similarly, it has been shown
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tube act as mitogens in the developing spinal cord (Mega-
son and McMahon 2002). It therefore is possible that in
a similar fashion, BMP and Wnt molecules may control
the balance between myogenic precursor proliferation
and differentiation in the head.
Wnt and BMP inhibitors are inducers of
cranial myogenesis
The repressive effect of BMP and Wnt signals on cranial
myogenesis implies that these factors need to be antago-
nized in order to promote muscle formation in the head.
In support of this idea, we found that the BMP inhibitors
Noggin and Gremlin, as well as the Wnt inhibitor Frzb,
are expressed in tissues surrounding the differentiating
cranial myoblasts. In vitro, Noggin and Gremlin strongly
supported myogenic differentiation of cranial mesoderm.
It is formally possible that other BMP antagonists in ad-
dition to Gremlin and Noggin may also play a role in
promoting cranial myogenesis. In contrast to the effects
of BMP antagonists, administration of the Wnt antago-
nist Frzb to cranial mesoderm, stimulated cardiogenesis
rather than skeletal muscle formation (Tzahor and Las-
sar 2001; this study), but when added in combination
with Noggin could enhance skeletal myogenesis. More-
over, Frzb was able to neutralize the repressive function
of the dorsal neural tube and restore myogenic differen-
tiation in the explant culture system. In vivo implanta-
tion of Frzb-IgG-expressing cells in the cranial paraxial
mesoderm similarly promoted the premature expression
of MyoD in the BAs. These findings suggest that Frzb
(and potentially other Wnt antagonists expressed in the
head; i.e., Sfrp-2 [Ladher et al. 2000]) may work in con-
junction with endogenous BMP inhibitors to promote
cranial myogenesis in the embryo.
Wnt and BMP inhibitors are expressed by both the
cranial neural crest and other tissues in the head
Our expression analysis revealed that the CNC cells are
a prominent source of BMP and Wnt inhibitors in the
head. Moreover, the presence of CNC or CNC-condi-
tioned medium triggered skeletal myogenesis of cranial
mesoderm explants in vitro in the same fashion as did
administration of either Noggin or Gremlin. The time
course of skeletal myogenesis in these cultures corre-
lated with the timing of expression of both these BMP
inhibitors and the Wnt inhibitor Frzb by the CNC cells
(data not shown), suggesting that secretion of these fac-
tors by CNC cells may act to promote cranial myogen-
esis in the head. This interpretation is in line with CNC
transplantation experiments in chick and genetic studies
in the zebrafish, suggesting a positive role for CNC cells
in the patterning of the head musculature (Noden
1983a,b; Schilling et al. 1996; Schilling and Kimmel
1997). CNC ablation in the frog led to complex changes
in muscle patterning, yet apparently not a loss of head
muscles (Olsson et al. 2001). Similarly, myogenic marker
genes were detected in the anlagen of the BAs as well as
the extraocular muscles following CNC ablation in the
chick (this study). Significantly, although the CNC-as-
sociated expression of marker genes including Frzb was
significantly diminished in these embryos, a low level of
Frzb expression throughout the BAs was often apparent,
whereas other sites of Frzb expression such as in the
ectoderm overlying the trigeminal ganglion and in the
distal BA ectoderm remained unaffected. Thus, it is un-
clear whether a small number of residual CNC cells re-
maining in these operated embryos or other redundant
sources of both BMP and Wnt antagonists secreted by
adjacent tissues allowed cranial myogenesis to occur in
these operated embryos. This issue can be more defini-
tively resolved by analyzing head muscle formation in
mice embryos engineered to lack either all or a subpopu-
lation of their CNC cells.
Model for the regulation of skeletal muscle formation
in the head
In summary (Fig. 7F–H), we have identified signals that
may act to modulate cranial muscle formation. Our find-
ings suggest that in the head, both BMPs and Wnts-1 and
-3a, which are secreted by the dorsal neural tube, act as
repressors of skeletal muscle formation, possibly to pre-
vent myogenic differentiation of the cranial mesoderm
in the vicinity of the neural tube (Fig. 7F). In stark con-
trast, these same Wnt molecules work in conjunction
with Shh to stimulate (epaxial) myogenesis in the trunk
(Fig. 7G). CNC cells, which surround the muscle anlagen
in the head, secrete both BMP inhibitors (Noggin, Grem-
lin) and Wnt inhibitors (Frzb), which we have found to
promote myogenic differentiation of the cranial meso-
derm (Fig. 7H). However, because removal of a substan-
tial amount of the CNC did not significantly negate the
cranial expression of Myf-5, we surmise that other tis-
sues in the head that similarly express either BMP and/or
Wnt antagonists may serve in a redundant capacity to
promote myogenic differentiation in the absence of CNC
cells.
Materials and methods
In situ hybridization (ISH)
Whole-mount ISH was performed as described (Riddle et al.
1993) and double in situ staining according to Mootoosamy and
Dietrich (2002). Chick DIG-labeled cRNA probes were gener-
ated from appropriate plasmids (available on request) encoding
either MyoD, Myf-5, BMP-4, BMP-7, Wnt-13, Shh, Gremlin,
Noggin, Frzb, or “Rsc” (probe for the RCAS virus).
Explant culture and analysis
Dissection of the cranial tissue explants was performed with
tungsten needles in Tyrode solution using 1% agar dishes as a
base. Techniques for CNC isolation and abation in vivo are
available upon request. Explants were cultured in serum-free
medium containing insulin, transferrin, and selenium and
supplemented with 2% chick embryo extract (Life Technolo-
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of 200 ng/mL, and BMP4 protein to 60 ng/mL, as previously
described (Murtaugh et al. 1999). Noggin or control-conditioned
medium prepared from CHO B3 or CHO dhfr- cells, respectively
(generously provided by Dr. Richard Harland, University of
California, Berkeley), as described (Murtaugh et al. 1999), was
used as a 75%:25% mixture of normal culture medium and
conditioned medium. Individual explants were lysed and RNA
was purified using a QIAGEN Rneasy minikit. RT-PCR was
performed to evaluate gene expression in single explants as de-
scribed in Munsterberg et al. (1995), and the PCR products am-
plified from the RNA of a single explant was separated by poly-
acrylamide gel electrophoresis. PCR primers used are available
on request.
Retroviral infection
RCAS constructs for GFP, Wnt-3a, a stabilized form of
-catenin, Wnt-13, Noggin (gift of Randy Johnson, M.D. Ander-
son Cancer Center), and Gremlin (gift of J.-C. Belmonte, Salk
Institute) were grown as described (Morgan and Fekete 1996).
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